Physician

Natalie Hale Wallace, MD, MPH

According to 2025 Medicare claims, Natalie Wallace, MD, MPH (NPI: 1386059061) practices hematology/oncology in the Anchorage, AK market, with the plurality of this provider's patient population coming from Anchorage, AK. This provider's primary affiliated billing organization is ALASKA ONCOLOGY AND HEMATOLOGY LLC (NPI: 1487713848; TIN: 92-0175249) and primary practice location at 99508-2959.

Wallace's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 400 traditional Medicare patients, billed 116,095 HCPCS/CPT codes, and received $2,803,374 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 653 prescription claims across 117 beneficiaries totaling $1,820,515 in drug costs, led by Tabrecta (Capmatinib Hydrochloride). DME data shows 51 claims. Open Payments data shows 85 records totaling $2,002. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $248,705 to $2,803,374. Similarly, Part D prescription costs have risen steadily, from $21,393 to $1,820,515. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.